What are generalized tonic‑clonic (grand mal) seizures?

What is Grand Mal Seizures?

Grand mal seizures, now medically termed generalized tonic-clonic seizures (GTCS), are the most severe and common type of convulsive epileptic seizure characterized by a two-phase pattern: an initial tonic phase with sudden loss of consciousness and muscle rigidity, followed by a clonic phase with rhythmic jerking movements of the limbs.

Clinical Characteristics

GTCS manifest through a distinctive sequence of events 1:

• Loss of consciousness occurs at seizure onset
• Tonic phase: Sudden muscle rigidity affecting the entire body, often causing the person to fall
• Clonic phase: Rhythmic jerking movements of arms and legs
• Associated features commonly include:
  • Frothing at the mouth 2
  • Urinary incontinence 2
  • Tongue biting or injury during the episode 2
  • Post-ictal confusion and drowsiness lasting minutes to hours

Classification and Types

GTCS are divided into two important categories 1:

Primary (Idiopathic) GTCS

• Genetically determined epilepsy syndromes
• Occur in normally developed individuals with normal brain structure
• Often have specific timing patterns (e.g., upon awakening) 3
• EEG shows generalized spike-wave discharges 4

Secondary GTCS

• Result from focal seizures that spread to involve the entire brain
• May indicate underlying brain lesions or symptomatic epilepsy
• Begin with focal features before generalizing 1

Epidemiology and Onset

GTCS typically begin during adolescence, with a median age of onset around 16-17 years 4, 5. They constitute approximately 31% of idiopathic generalized epilepsy cases 5 and represent 5.7% of all childhood seizure disorders 6.

Diagnostic Criteria

A clinical case definition for GTCS requires at least 4 of the following 6 features 2:

1. Absence of psychological stress as a trigger
2. Frothing at the mouth during the episode
3. Occurrence during sleep
4. Urinary incontinence
5. Loss of consciousness
6. Injury sustained during the episode

This definition provides 72% sensitivity and 100% specificity for identifying GTCS 2.

Prognosis

The natural history of GTCS is generally favorable 6:

• 95% of patients achieve seizure freedom with appropriate treatment during long-term follow-up
• Early onset in normally developed children predicts better outcomes
• Most patients respond quickly to antiseizure medications
• Drug resistance occurs in only 16.3% of cases 4

Seizure Control Patterns

Long-term follow-up reveals distinct patterns 4:

• Early remission: 34.3% of patients
• Late remission: 17.9% of patients
• Relapsing-remitting: 36.3% of patients
• No remission: 8% of patients

Important Clinical Pitfalls

High relapse rates occur after medication discontinuation 3, 5:

• 75% of patients relapse 6 months to 1 year after stopping antiseizure medications 3
• 44% experience recurrence after attempted withdrawal 5
• Patient-initiated (versus physician-supervised) medication tapering significantly increases relapse risk 5

Precipitating factors to counsel patients about 3:

• Sleep deprivation (most common trigger)
• Photostimulation
• Hyperventilation
• Menstruation in females
• Febrile illness

EEG Findings

Initial EEG typically shows 4, 5:

• Generalized spike-wave discharges (present in 88% of patients)
• 3-4 Hz generalized spike-wave complexes
• Activation with photostimulation or hyperventilation
• Normal background activity between seizures